A prospective study of surgery combined with concurrent radiochemotherapy in the treatment of patients with early stage nasopharyngeal carcinoma.
- Author:
Yongfeng SI
1
;
Zhongqiang TAO
;
Zheng ZHANG
;
Yangda QIN
;
Fuling ZHOU
;
Bo HUANG
;
Jinlong LU
;
Bing LI
;
Guiping LAN
;
Jingjin WENG
Author Information
1. Department of Otorhinolaryngology-Head and Neck Neoplasm, Institute of Nasopharyngeal Carcinoma, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, China. syfklxf@yahoo.com.cn
- Publication Type:Journal Article
- MeSH:
Aged;
Carcinoma;
Chemoradiotherapy;
Combined Modality Therapy;
methods;
Disease-Free Survival;
Follow-Up Studies;
Humans;
Incidence;
Nasopharyngeal Carcinoma;
Nasopharyngeal Neoplasms;
mortality;
pathology;
surgery;
therapy;
Nasopharynx;
radiation effects;
Neoplasm Staging;
Prospective Studies;
Radiotherapy Dosage;
Survival Rate;
Xerostomia;
epidemiology;
etiology
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2012;26(9):422-425
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical value that surgical treatment with comprehensive treatment in treating early stage nasopharyngeal carcinoma.
METHOD:Based on the case selection criteria, patients with early nasopharyngeal carcinoma were divided into surgery group and the conventional group according to patients' wishes. Surgery group were treated with surgery plus Radiochemotherapy as a comprehensive treatment while conventional group were treated with Radiochemotherapy. Outcome indices: (1) 5-year survival rate and 5-year disease-free survival rate; (2) Radiation dose to the nasopharynx; (3) Incidence of xerostomia.
RESULT:(1) The overall 5-year follow-up rate was 97.12%; 1 patient was lost to follow-up in surgical group, the 5-year follow-up rate was 96.77%; 2 patients were lost in conventional Group with 5-year rate of 97.26%. (2) The 5-year survival rate of 104 patients was 83.65% (87/104). (3) The 5-year survival rate and 5-year tumor-free survival rate were 96.77% (30/31) and 93.55% (29/31) in surgical group, 78.08% (57/73) and 73.97% (54/73) in conventional group. There were significant differences between the two groups (P < 0.05). (4) The radiation dose to the nasopharynx in surgery group and conventional group were (63.90 +/- 5.56) Gy and (71.48 +/- 4.18)Gy, respectively; the dose in surgical group was significantly less than the conventional group, there were statistical significance between the two groups. (5) The incidence of xerostomia was significantly less in surgical group (22.58%) than conventional group (65.75%), the difference was statistically significant.
CONCLUSION:The surgery combined with concurrent chemoradiotherapy is a effective comprehensive therapeutic interchange program for early stage nasopharyngeal carcinoma. These program can increase the long-term survival rate, but also reduce the radiation dose to the nasopharynx and the occurrence of radiation complications. A further aspect is worth consideration.
